GSMG(SH:600543)2023-04-27 16:00Financial Performance - The company's operating revenue for Q1 2023 reached ¥51,783,283.55, representing a year-on-year increase of 85.57%[3] - The net profit attributable to shareholders of the listed company was -¥3,590,601.99, with a year-on-year increase of ¥5,911,700 due to improved operating performance[4] - In Q1 2023, the company reported a net loss of CNY 4,174,283.43, compared to a net loss of CNY 10,680,606.57 in Q1 2022, indicating an improvement of approximately 61.0% year-over-year[17] - Operating profit for Q1 2023 was CNY -3,852,038.93, significantly better than the loss of CNY 10,987,232.50 in the same period last year, reflecting a reduction in operating losses[17] - Total revenue from sales of goods and services reached CNY 48,114,977.91 in Q1 2023, up from CNY 30,940,945.50 in Q1 2022, representing a growth of approximately 55.7%[21] - The total comprehensive income attributable to the parent company was CNY -3,590,601.99 in Q1 2023, an improvement from CNY -9,502,270.42 in Q1 2022, showing a reduction in losses of about 62.2%[18] - Basic and diluted earnings per share for Q1 2023 were both CNY -0.01, compared to CNY -0.03 in Q1 2022, indicating a decrease in loss per share[18] Revenue Breakdown - The wine business generated sales revenue of ¥20,183,400, a 30.13% increase from ¥15,510,800 in the same period last year[4] - Sales revenue from biodegradable materials and products reached ¥11,348,800, up 38.87% from ¥8,172,200 year-on-year[4] - Pharmaceutical sales revenue surged to ¥16,171,600, marking a 413.58% increase from ¥3,148,800 in the previous year[4] Cash Flow and Assets - The cash flow from operating activities increased by ¥53,555,000 compared to the same period last year, primarily driven by higher operating revenue and reduced raw material procurement for biodegradable materials[4] - The company's cash and cash equivalents increased to ¥219,317,337.45 from ¥211,744,112.81, showing a growth of 3.0%[11] - The net cash flow from operating activities was CNY 7,992,928.60 in Q1 2023, a significant recovery from a negative cash flow of CNY -45,562,108.55 in Q1 2022[22] - The total operating cash outflow decreased to CNY 46,445,021.45 in Q1 2023 from CNY 86,688,139.91 in Q1 2022, reflecting improved cash management[22] Costs and Expenses - Total operating costs for Q1 2023 were ¥55,941,044.94, up 42.8% from ¥39,194,572.71 in Q1 2022[16] - Operating costs included ¥35,591,786.32 in cost of goods sold, which rose from ¥19,848,095.47 in the previous year, reflecting a 79.6% increase[16] - The company increased its R&D expenses by 69.13%, focusing on the development of biodegradable materials and products[7] - The company incurred research and development expenses of CNY 250,688.07 in Q1 2023, compared to CNY 148,219.50 in Q1 2022, marking an increase of approximately 68.9%[17] Balance Sheet Highlights - The total assets at the end of the reporting period were ¥1,082,043,152.25, a decrease of 0.98% from the previous year-end[3] - As of March 31, 2023, total assets amounted to ¥1,082,043,152.25, a decrease from ¥1,092,755,322.02 at the end of 2022[12] - Total liabilities decreased to ¥165,133,004.08 from ¥171,670,890.42 at the end of 2022, indicating a reduction of 3.3%[13] - The company's equity attributable to shareholders decreased to ¥958,686,902.55 from ¥962,277,504.54, a decline of 0.4%[13] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 34,632[9] - The number of shares held by the top ten unrestricted shareholders includes Gansu Agricultural Reclamation Group with 45,819,636 shares, representing a significant concentration of ownership[10] Other Income - The company reported other income of CNY 305,722.46 in Q1 2023, slightly up from CNY 302,850.92 in Q1 2022, indicating stable additional income sources[17]